Erythromycin acts by interfering with:
**Core Concept**
Erythromycin is a macrolide antibiotic that inhibits protein synthesis in bacteria by binding to the 50S ribosomal subunit. This action prevents the translocation of peptidyl-tRNA to the A site, thereby blocking the elongation of the polypeptide chain.
**Why the Correct Answer is Right**
Erythromycin binds to the 50S ribosomal subunit and inhibits the action of peptidyl transferase, an enzyme responsible for forming peptide bonds between amino acids. This binding disrupts the normal function of the ribosome, leading to the inhibition of protein synthesis. As a result, bacterial growth and replication are halted, and the bacteria are killed.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because Erythromycin does not act by inhibiting DNA replication or transcription.
**Option B:** Incorrect because Erythromycin does not act by interfering with cell wall synthesis.
**Option C:** Incorrect because Erythromycin does not act by inhibiting the synthesis of essential bacterial metabolites.
**Clinical Pearl / High-Yield Fact**
Erythromycin is a bacteriostatic agent, meaning it inhibits the growth of bacteria without necessarily killing them. However, in the presence of other antibiotics that are bactericidal, erythromycin can become bactericidal, making it a useful addition to combination regimens.
**Correct Answer: A. Inhibiting protein synthesis by binding to the 50S ribosomal subunit.**